5-(2-amino-1-ethyl)thio-3-isopropyl-7-[4-(pyrazin-2-yl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidine

ID: ALA5187378

Chembl Id: CHEMBL5187378

PubChem CID: 168279648

Max Phase: Preclinical

Molecular Formula: C21H24N8S

Molecular Weight: 420.55

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1n[nH]c2c(NCc3ccc(-c4cnccn4)cc3)nc(SCCN)nc12

Standard InChI:  InChI=1S/C21H24N8S/c1-13(2)17-18-19(29-28-17)20(27-21(26-18)30-10-7-22)25-11-14-3-5-15(6-4-14)16-12-23-8-9-24-16/h3-6,8-9,12-13H,7,10-11,22H2,1-2H3,(H,28,29)(H,25,26,27)

Standard InChI Key:  ORQQCLLJNPKLIL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5187378

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NU-DUL-1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DB (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OCI-LY19 (76 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2932 (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SUD4 (402 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND1 Tchem Cyclin-dependent kinase 2/G1/S-specific cyclin-D1 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNK Tbio CDK12/Cyclin K (892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK13 Tchem Cyclin-dependent kinase 13/Cyclin-K (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.55Molecular Weight (Monoisotopic): 420.1845AlogP: 3.60#Rotatable Bonds: 8
Polar Surface Area: 118.29Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.59CX Basic pKa: 9.38CX LogP: 2.57CX LogD: 0.80
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.29Np Likeness Score: -1.48

References

1. Jorda R, Havlíček L, Peřina M, Vojáčková V, Pospíšil T, Djukic S, Škerlová J, Grúz J, Renešová N, Klener P, Řezáčová P, Strnad M, Kryštof V..  (2022)  3,5,7-Substituted Pyrazolo[4,3-d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders.,  65  (13.0): [PMID:35749742] [10.1021/acs.jmedchem.1c02184]

Source